Suppr超能文献

基于荟萃分析,增加linc00261的表达可能预示着良好的癌症预后。

Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis.

作者信息

He Xinyue, Fang Shixu, Wu Chen, Na Jintong, Zhong Liping, Liu Xiyu

机构信息

State Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical University, Nanning, 530021, Guangxi, China.

出版信息

Discov Oncol. 2025 Jul 1;16(1):1205. doi: 10.1007/s12672-025-02908-2.

Abstract

BACKGROUND

linc00261 was reported to be deregulated in many tumor groups and was significantly associated with cancer prognosis. This investigation seeks to conduct a meta-analysis to explore the link between linc00261 levels and cancer outcomes.

METHODS

Electronic databases underwent comprehensive searching, and appropriate publications were filtered per the predetermined selection criteria. For each included literature, we implemented a quality assessment (NOS score) and obtained relevant data in detail. The link between linc00261 level and cancer outcomes was investigated through pooled HR and OR analysis with 95%CI. Sensitivity analysis was utilized to examine the stability and dependability of the consolidated findings. In the meantime, Begg's test was carried out to evaluate whether there exists significant publication bias or other bias in the original literature.

RESULTS

The linc00261 level exhibited reduction in the majority of tumor tissues, where enhanced linc00261 levels demonstrated substantial correlation with favorable cancer outcomes, encompassing overall survival (OS) (hazard ratio (HR): 0.497, 95% CI: 0.408-0.586), disease-free survival (DFS) (HR: 0.38, 95% CI: 0.25-0.59) and progression-free survival (PFS) (HR: 0.31, 95% CI: 0.18-0.53). Moreover, increased linc00261 levels indicated earlier TNM stages (odds ratio (OR): 0.542, 95%CI: 0.442-0.663), reduced susceptibility to distant lymph node metastasis (LNM) (OR: 0.674, 95%CI: 0.550-0.826), distant metastasis (DM) (OR: 0.579, 95%CI: 0.420-0.798), reduced tumor size (OR: 0.705, 95%CI: 0.564-0.880) and improved histological grade (OR: 0.906, 95%CI: 0.694-1.183). Sensitivity analysis outcomes suggest that individual studies demonstrate minimal influence on the comprehensive findings. The Begg's test outcomes suggest that the original study had no significant publication or other biases.

CONCLUSIONS

The expression of linc00261 is decreased in many tumor tissues, high linc00261 expression indicates a satisfied prognosis of cancer. linc00261 could function as a candidate therapeutic target and an encouraging prognostic indicator for tumors.

摘要

背景

据报道,linc00261在许多肿瘤组中表达失调,且与癌症预后显著相关。本研究旨在进行一项荟萃分析,以探讨linc00261水平与癌症结局之间的联系。

方法

对电子数据库进行全面检索,并根据预定的选择标准筛选合适的出版物。对于每一篇纳入的文献,我们进行了质量评估(NOS评分)并详细获取相关数据。通过合并风险比(HR)和比值比(OR)分析及95%置信区间,研究linc00261水平与癌症结局之间的联系。采用敏感性分析来检验综合结果的稳定性和可靠性。同时,进行Begg检验以评估原始文献中是否存在显著的发表偏倚或其他偏倚。

结果

大多数肿瘤组织中linc00261水平降低,linc00261水平升高与良好的癌症结局显著相关,包括总生存期(OS)(风险比(HR):0.497,95%置信区间:0.408 - 0.586)、无病生存期(DFS)(HR:0.38,95%置信区间:0.25 - 0.59)和无进展生存期(PFS)(HR:0.31,95%置信区间:0.18 - 0.53))。此外,linc00261水平升高表明TNM分期较早(比值比(OR):0.542,95%置信区间:0.442 - 0.663)、远处淋巴结转移(LNM)易感性降低(OR:0.674,95%置信区间:0.550 - 0.826)、远处转移(DM)(OR:0.579,95%置信区间:0.420 - 0.798)、肿瘤大小减小(OR:)0.705,95%置信区间:0.564 - 0.880)和组织学分级改善(OR:0.906,95%置信区间:0.694 - 1.183)。敏感性分析结果表明,个别研究对综合结果的影响最小。Begg检验结果表明,原始研究无显著的发表偏倚或其他偏倚。

结论

许多肿瘤组织中linc00261表达降低,linc00261高表达表明癌症预后良好。linc00261可作为肿瘤的候选治疗靶点和有前景的预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3733/12214098/60ac3c97b354/12672_2025_2908_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验